Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer

American Journal of Surgery

Volumn 195, Issue 4, 2008, Pages 457-462

  Kushchayeva, Yevgeniya ^a   Duh, Quan Yang ^a   Kebebew, Electron ^a   D'Avanzo, Alessandra ^a   Clark, Orlo H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Follicular cancer; Hurthle cell; Risk factors

Indexed keywords

IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE FREE INTERVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; ONCOCYTOMA; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURGICAL APPROACH; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA; ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 40949154349     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.06.001     Document Type: Article

References (40)

1. Bogdanova T.I., Kozuritskii B.G., and Tronko N.D. Thyroid Pathology in Children (2000), Chernobulinterinform, Kiev
2. Yutan E., and Clark O. Hurthle cell carcinoma. Curr Treat Options Oncol 2 (2001) 331-335
3. Grebe S., and Hay I. Follicular thyroid cancer. Endocrinol Metab Clin North Am 24 (1995) 761-801
4. Shore R.E. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 131 (1992) 98-111
5. Arganini M., Behar R., Wu T., et al. Hurthle cell tumors: a twenty-five-tear experience. Surgery 100 (1986) 1108-1114
6. Canzian F., Amati P., Harach H., et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63 (1998) 1743-1748
7. Sugino K., Koichi I., Mimura T., et al. Hurthle cell tumor of the thyroid: analysis of 188 cases. World J Surg 25 (2001) 1160-1163
8. Lopez-Penabad L., Chiu A., Hoff A., et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer 97 (2003) 1186-1194
9. Ruegemer J., Hay I., Bergstralh E., et al. Distant metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 67 (1988) 501-508
10. Brennan M.D., Bergstral E.J., van Heerden J.A., and McConahay W.M. Follicular thyroid cancer treated at the Mayo Clinic, 1946-1970: initial manifestation, pathological findings, therapy and outcome. Mayo Clinic Proc 66 (1991) 11-22
11. Rosai J., Carcangiu M., and Dellelis R. Atlas of Tumor Pathology. Tumor of the Thyroid gland (1992), Armed Forces Institute of Pathology, Bethesda, MD
12. Herrera M., Hay J., Wu P., et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg 16 (1992) 669-675
13. Shaha A., Loree T., and Shah J. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118 (1995) 1131-1138
14. McDonald M., Sanders L., Silverman M., et al. Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120 (1996) 1000-1005
15. Grant C.S. Operative and postoperative management of the patients with follicular and Hurthle cell carcinoma: do they differ?. Surg Clin North Am 75 (1995) 395-403
16. DeGroot L.J., Kaplan E.L., Shukla M.S., et al. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80 (1995) 2946-2953
17. Khafif A., Khafif R., and Attie J. Hurthle cell carcinoma: a malignancy of low-grade potential. Head Neck 21 (1999) 506-511
18. Bhattacharyya N. Survival and prognosis in Hurthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg 129 (2003) 207-210
19. Sanders L., and Silverman M. Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy. Surgery 124 (1998) 967-974
20. Evans H., and Vassilopoulou-Sellin R. Follicular and Hurthle cell carcinoma of the thyroid. A comparative study. Am J Surg Pathol 22 (1998) 1512-1520
21. Kushchayeva Y., Duh Q.Y., Kebebew E., and Clark O.H. Prognostic indications for Hurthle cell cancer. World J Surg 28 (2004) 1266-1270
22. D'Avanzo A., Treseler P., Ituarte P., et al. Follicular thyroid carcinoma: histology and prognosis. Cancer 1000 (2004) 1123-1129
23. Stojadinovic A., Hoos A., Ghossein R., et al. Hurthle cell carcinoma: a 60-years experience. Ann Surg Oncol 9 (2002) 197-203
24. Clark O., and Gerand P. Thyrotropin receptor adenylate cyclase system in Hurthle cell neoplasms. J Clin Endocrinol Metab 61 (1985) 773-778
25. Chow S.-M., Law K.S., Mendenhall W.M., et al. Follicular thyroid carcinoma. Prognostic factors and the role of radioiodine. Cancer 95 (2002) 488-498
26. Samaan N., Maheshwari Y., Nader S., et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56 (1983) 1131-1138
27. Har-El G., Hadar T., Segal K., et al. Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 57 (1986) 1613-1617
28. De Groot L.J., Kaplan E.L., Shukla M.S., et al. Morbidity and mortality in follicular cancer. J Clin Endocrinol Metab 80 (1995) 2946-2953
29. Sherman S.I., Brierley J.D., Sperling M., et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83 (1998) 1012-1021
30. Goldstein N., Czako P., and Neill J. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol 13 (2001) 123-130
31. Mai K., Khanna P., Yazdi H., et al. Differentiated thyroid carcinoma with vascular invasion: a comparative study of follicular, Hurthle cell and papillary thyroid carcinoma. Pathology 34 (2002) 239-244
32. Thompson L.D., Wieneke J.A., Paal E., et al. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91 (2001) 505-524
33. McHenry C., and Sandoval B. Management of follicular and Hurthle cell neoplasms of the thyroid gland. Surg Oncol Clin North Am 7 (1998) 893-910
34. Cooper S., and Schneyer C. Follicular and Hurthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 19 (1990) 577-591
35. Perrier N., Ituarte P., Treseler P., et al. Classification and treatment of follicular thyroid neoplasm are discordant between and within medical specialties. Surgery 126 (1999) 1063-1069
36. D'Avanzo A., Ituarte P., Treseler P., et al. Prognostic scoring system in patients with follicular cancer: a comparison of different staging system in predicting the patients outcome. Thyroid 14 (2004) 453-458
37. Emerick G.T., Duh Q.-Y., Sipersteine A.E., et al. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 72 (1993) 3287-3295
38. Samaan N.A., Schulttz P.N., Hickey R.C., et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75 (1992) 714-720
39. Foote R.L., Brown P.D., Garces Y.I., et al. Is there a role for radiation therapy in the management of Hurthle cell carcinoma?. Int J Radiat Oncol Biol Phys 56 (2003) 1067-1072
40. Simpson W.J., Panzarella T., Carruthers J.S., et al. Papillary and follicular thyroid cancer: impact of treatment in 1,578 patients. Int J Radiat Oncol Biol Phys 14 (1988) 1063-1075